ATPW
INDV icon

Ashton Thomas Private Wealth’s Indivior Pharmaceuticals INDV Stock Holding History

Ashton Thomas Private Wealth’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$432K Buy
10,537
+3,462
+49% +$126K 0.01% 836
2026
Q1 		$216K Buy
+7,075
New +$234K 0.01% 1004

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ashton Thomas Private Wealth's INDV Position: Q2 2026 in Review

Ashton Thomas Private Wealth increased its Indivior Pharmaceuticals (INDV) stake by 49% in Q2 2026, buying an estimated $126K and bringing the position to 10,537 shares worth $432K. The position accounts for 0.01% of the portfolio, ranked #836.

Ashton Thomas Private Wealth first reported a position in INDV in Q1 2026 and has held it in 2 quarters since. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Ashton Thomas Private Wealth held 10,537 shares of Indivior Pharmaceuticals worth $432K as of Q2 2026.
  • Ashton Thomas Private Wealth bought 3,462 Indivior Pharmaceuticals shares in Q2 2026, an estimated $126K.
  • Indivior Pharmaceuticals made up 0.01% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #836 holding.
  • Ashton Thomas Private Wealth first reported a position in Indivior Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.